Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

Abstract

These data indicate that ovarian tumors are enriched with CSCs and stem cell pathway mediators, especially at the completion of primary therapy. This suggests that stem cell subpopulations contribute to tumor chemoresistance and ultimately recurrent disease.